Breaking News Instant updates and real-time market news.

BA

Boeing

$172.76

1.9495 (1.14%)

, CSCO

Cisco

$33.60

0.78 (2.38%)

14:37
02/17/17
02/17
14:37
02/17/17
14:37

Trump Effect: Week In Review

President Donald Trump's meetings with top executives of major U.S. companies continued this week. Trump sat down with retail industry leaders on Wednesday and with Boeing (BA) on Friday. Meanwhile, Oppenheimer analyst Ittai Kidron told investors in a research note that he sees Cisco Systems (CSCO) benefiting "substantially" from the expected tax reform under the new administration. CISCO: Commenting on the impact of President Trump's tax reform, and particularly a potential cash repatriation, Oppenheimer's Kidron told investors earlier in the week that he believes Cisco Systems stands to benefit "substantially" given the company's "massive" foreign cash balance. Kidron pointed out that there could be a temporary tax holiday during which U.S. companies could repatriate foreign earnings at a reduced tax rate, or a permanent change in the tax code that lowers the top marginal rate and/or moves to a territorial system that does not tax overseas earnings. Both offer "strong upside" to Cisco's earnings per share and stock price, he contented. RETAIL INDUSTRY: On Wednesday, President Donald Trump met with the Retail Industry Leaders Association, along with chief executives of Target (TGT), Best Buy (BBY), Gap (GPS), Autozone (AZO), Walgreens Boots Alliance (WBA), J.C. Penney (JCP), Tractor Supply (TSCO), and Jo-Ann Stores to discuss tax reform and infrastructure investment. Speaking in front of cameras from the White House during the meeting, Trump said the industry has a big "regulatory problem" that he is going to take care. The President also noted that he is cutting regulations in every industry, adding that tax reform is one of the best ways to help the economy. H&R BLOCK: During the meeting with retail CEOs in the White House, President Donald Trump also mentioned H&R Block (HRB), saying that the tax preparer "will not be happy" with the upcoming tax reform under the new administration. "We're going to simplify very greatly the tax code. It's too complicated. H&R Block probably won't be too happy. That's one business that might not be happy with what we're doing," the President said. BOEING: On Friday, President Donald Trump flew to Charleston, South Carolina to participate in the unveiling of Boeing's new 787-10 Dreamliner, a long-haul airplane that can accommodate more than 300 passengers. Additionally, the President said on Twitter that he would "talk jobs" with the company's management. This comes just two days after an attempt to unionize the plant fell far short. "Trump Effect: Week in Review" is The Fly's weekly recap of its recurring series of "Trump Effect" exclusive stories that highlight stocks that are being impacted, or are predicted to be impacted, by the comments, actions and policies of President Trump and his administration.

BA

Boeing

$172.76

1.9495 (1.14%)

CSCO

Cisco

$33.60

0.78 (2.38%)

TGT

Target

$65.66

0.4599 (0.71%)

BBY

Best Buy

$45.16

-0.215 (-0.47%)

GPS

Gap

$24.39

0.33 (1.37%)

AZO

AutoZone

$739.13

1.77 (0.24%)

WBA

Walgreens Boots Alliance

$85.65

1.4 (1.66%)

JCP

J.C. Penney

$6.99

-0.04 (-0.57%)

TSCO

Tractor Supply

$70.85

-1.88 (-2.58%)

  • 17

    Feb

  • 21

    Feb

  • 22

    Feb

  • 23

    Feb

  • 24

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 03

    Mar

  • 19

    Mar

BA Boeing
$172.76

1.9495 (1.14%)

02/13/17
BUCK
02/13/17
DOWNGRADE
Target $140
BUCK
Underperform
Boeing downgraded to Underperform from Neutral at Buckingham
Buckingham downgraded Boeing to Underperform and raised its price target to $140 from $100 saying at current levels, shares are priced for perfection and reflect optimistic free-cash-flow estimates. The firm's analyst expects Boeing shares to underperform on downward estimate revisions, a series of negative catalysts, and multiple compression.
01/26/17
BERN
01/26/17
NO CHANGE
BERN
Boeing reported strong Q4 results, says Bernstein
After Boeing reported higher than expected Q4 EPS, Bernstein analysts Douglas Harned and Christian Laughlin call the results "strong" and say that the company's 2017 guidance is "very positive." The analysts expect the company to benefit from strong cash flow growth, and they keep a $191 price target and an Outperform rating on the shares.
01/27/17
BERN
01/27/17
NO CHANGE
BERN
Boeing price target raised to $208 from $191 at Bernstein
Bernstein analyst Douglas Harned believes that Boeing reported "strong" Q4 results, and he notes that the company's 2017 operating and free cash flow guidance surpassed his expectations. The analyst expects the company's cash flow growth to be "steady," and he keeps an Outperform rating on the stock.
02/13/17
02/13/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Boeing (BA) downgraded to Underperform from Neutral at Buckingham with the firm saying at current levels, shares are priced for perfection and reflect optimistic free-cash-flow estimates. The firm's analyst expects Boeing shares to underperform on downward estimate revisions, a series of negative catalysts, and multiple compression. 2. Reynolds American (RAI) downgraded to Sector Perform from Outperform at RBC Capital. 3. Occidental Petroleum (OXY) downgraded to Neutral from Buy at Mizuho with analyst Timothy Rezvan citing valuation, muted dividend growth, and increasing unit expense trends. 4. AK Steel (AKS) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Evan Kurtz saying he is concerned about AK's exposure to electrical steel and heavy auto steel, which could prove to be headwinds this year. 5. Williams-Sonoma (WSM) downgraded to Market Perform from Outperform at Telsey Advisory with analyst Cristina Fernandez saying the company is fighting a more competitive environment and softer consumer spending by aggressively increasing promotions to maintain share. The analyst is surprised by the high level of promotions at West Elm and said some real estate contacts have noted softening store sales in December. Fernandez said the turnaround at Pottery Barn could take longer and sees limited margin expansion in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CSCO Cisco
$33.60

0.78 (2.38%)

02/16/17
UBSW
02/16/17
NO CHANGE
Target $37
UBSW
Buy
Cisco not ruling out any sized deal, says UBS
UBS analyst Steven Milunovich noted Cisco delivered a slight Q2 beat and inline Q3 guidance. The analyst said he sensed urgency in management's tone during the conference call, while the CEO said they are not ruling out any size deal and M&A doesn't depend on cash repatriation. Milunovich maintained his Buy rating and raised his price target to $37 from $35 on Cisco shares.
02/16/17
DBAB
02/16/17
NO CHANGE
Target $40
DBAB
Buy
Cisco price target raised to $40 from $37 at Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath raised his price target for Cisco Systems to $40 saying the company's Q2 results are "better than feared." The analyst reiterates a Buy rating on the shares.
02/16/17
SBSH
02/16/17
NO CHANGE
Target $37
SBSH
Buy
Cisco price target raised to $37 from $34 at Citi
Citi analyst Jim Suva raised his price target for Cisco Systems to $37 citing the company's "solid" Q2 beat and "good" guidance. The analyst expects to see margin expansion as new products ramp in FY17 and Enterprises begin to virtualize more of their hardware. He reiterates a Buy rating on the shares.
02/16/17
BERN
02/16/17
NO CHANGE
BERN
Cisco reported 'solid' results, says Bernstein
Bernstein analyst Pierre Ferragu says that Cisco reported "solid" results, and the analyst, noting that Cisco's deferred revenues related to subscriptions rose about 5.1%, says that his thesis on the growth of its subscriptions business is playing out. Ferragu raised his price target on the stock to $37 from $35 and keeps an Outperform rating on the shares.
TGT Target
$65.66

0.4599 (0.71%)

02/07/17
02/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Target (TGT) and Dollar General (DG) were initiated with an Outperform at Bernstein, while Lowe's (LOW) was initiated with an Underperform. The firm also initiated Costco (COST), Home Depot (HD), and Wal-Mart (WMT) with a Market Perform. 2. Aetna (AET) and UnitedHealth (UNH) were assumed with an Overweight at Cantor. 3. Philips (PHG) initiated with a Hold at Berenberg. 4. Costamare (CMRE) initiated with a Neutral at Citi. 5. BioMarin (BMRN) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/13/17
PIPR
02/13/17
NO CHANGE
Target $83
PIPR
Overweight
Target risk/reward compelling ahead of investor day, says Piper Jaffray
Piper Jaffray analyst Sean Naughton says Target's (TGT) risk/reward is "compelling" ahead of the company's investor day. The stock, trading at a 21% discount to most direct peer Wal-Mart (WMT), is pricing in much of the near-term downside, Naughton tells investors in a research note. Target is "under-loved" and remains a "great brand with good assets and strong free cash flow," the analyst contends. He keeps an Overweight rating on the shares with an $83 price target.
02/10/17
SUSQ
02/10/17
INITIATION
Target $70
SUSQ
Neutral
Target initiated with a Neutral at Susquehanna
Target $70.
02/14/17
CLVD
02/14/17
NO CHANGE
CLVD
Target 2017 outlook becoming more cautious at Cleveland Research
Cleveland Research analyst Scott Bender said Target's January sales appear to have been slightly better vs. November/December due to easier comparisons and clearance activity in discretionary categories, offset by weakness in grocery. Bender still see 4Q comps trending in line with consensus and guidance but said the 2017 outlook appears to be getting incrementally more cautious due to competitive headwinds, lack of sales-driving catalysts, increased focus on margins, and internal changes that may cause disruptions.
BBY Best Buy
$45.16

-0.215 (-0.47%)

12/06/16
LOOP
12/06/16
INITIATION
Target $58
LOOP
Buy
Best Buy initiated with a Buy at Loop Capital
Loop Capital initiated Best Buy with a Buy rating and $58 price target.
01/05/17
OPCO
01/05/17
NO CHANGE
OPCO
Traditional chains fighting back as Amazon remains leader, says Oppenheimer
Oppenheimer analyst Brian Nagel says that during the Holiday season his firm ordered one item from eight Hardlines/Broadlines retailers and performed an informal test to see how the shopping experience compared to Amazon (AMZN). While the analyst notes that the e-commerce giant remains the leader online, he says traditional chains are fighting back with sharper pricing and improvements to fulfillment and return capabilities. Among traditional chains, Bed Bath & Beyond (BBBY), Costco (COST), and Wal-Mart (WMT) performed best on pricing, while Best Buy (BBY) scored as the best in fulfillment, Nagel says.
01/24/17
01/24/17
NO CHANGE

Sector Weight
Pacific Crest raises GoPro estimates on 'better than feared' checks
In a research note titled "You Heard Correctly: We Are Raising Estimates on GPRO," Pacific Crest analyst Brad Erickson said his channel checks indicate GoPro's (GPRO) Q4 turned out "better than feared." The quarterly earnings report, amid high short interest and negative sentiment, could give the stock a "near-term reprieve," Erickson tells investors. Specifically, the analyst's checks show GoPro exited the quarter with a "healthy" 7-8 days of inventory at Best Buy (BBY) in the United States. Erickson raised his Q4 earnings per share estimate for the company to 29c from 22c, above the consensus at 23c. He believes, however, that the action camera market remains saturated and keeps a Sector Weight rating on GoPro. Erickson remains "convinced" that the shares are fairly valued in the $9-$10 range. The action camera maker closed yesterday down 11c to $9.40.
02/06/17
BERN
02/06/17
INITIATION
Target $34
BERN
Underperform
Best Buy initiated with an Underperform at Bernstein
Target $34.
GPS Gap
$24.39

0.33 (1.37%)

11/28/16
MSCO
11/28/16
NO CHANGE
MSCO
Softline Black Friday weekend sales mixed versus last year, says Morgan Stanley
Morgan Stanley said overall Softline Black Friday weekend sales were mixed verus last year saying L Brands (LB), lululemon (LULU), and Hollister were weekend winners and Gap (GPS), Broadridge (BR), Michael Kors (KORS), and Anthro were laggards.
01/06/17
BARD
01/06/17
NO CHANGE
Target $26
BARD
Neutral
Gap estimates raised but risk/reward remains balanced, says Baird
Baird analyst Mark Altschwager noted Gap reported better than expected comps buoyed by Old Navy and the company signaled modest upside to guidance. The analyst raised his estimates but said visibility into sustainable sales/margin improvement remains cloudy, yielding a balanced risk/reward at current levels. Altschwager maintained his Neutral rating and $26 price target on Gap shares.
12/19/16
12/19/16
NO CHANGE

Wells Fargo identifies retailers most at risk from Trump policies
Wells Fargo says that apparel retailers, footwear makers, and watch makers import large amounts and have low gross margins. As a result, the firm believes that such companies face the most risk from upcoming federal policy changes, and it is more cautious on Carter's (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil (FOSL), and Gap (GPS).
02/07/17
JEFF
02/07/17
NO CHANGE
Target $36
JEFF
Buy
Jefferies calls on Gap to consider alternatives for Banana
While the Gap brand last night reported its second consecutive month of positive comparable sales, and Old Navy remained positive, Banana Republic continued to struggle with comp sales down 4%, Jefferies analyst Randal Konik tells investors in a research note. Management needs to take action, the analyst argues. He believes management should consider strategic alternatives for Banana including a potential sale, massively reducing the store footprint, or shutting down the brand. Konik has a Buy rating on Gap with a $36 price target.
AZO AutoZone
$739.13

1.77 (0.24%)

01/18/17
01/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. AutoZone (AZO) and O'Reilly Automotive (ORLY) were initiated with a Buy at Guggenheim, while the firm initiated Advance Auto Parts (AAP) with a Neutral. 2 Kansas City Southern (KSU) was initiated with a Buy at Buckingham, while the firm initiated Norfolk Southern (NSC) and Union Pacific (UNP) with a Neutral. 3. Fortive (FTV) initiated with a Perform at Oppenheimer. 4. Halliburton (HAL) was initiated with a Buy at SunTrust, while the firm initiated Helmerich & Payne (HP) with a Sell. The firm also initiated Baker Hughes (BHI) and Schlumberger (SLB) with a Hold. 5. Expedia (EXPE) was initiated with a Strong Buy at Miller Tabak, while the firm initiated Priceline (PCLN) with a Buy and TripAdvisor (TRIP) with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/14/16
12/14/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Dunkin' Brands (DNKN) initiated with a Market Perform at Cowen. 2. Sonic (SONC) initiated with a Market Perform at Cowen. 3. Advance Auto Parts (AAP) was initiated with an Overweight at Atlantic Equities while the firm initiated AutoZone (AZO), Genuine Parts (GPC), and O'Reilly Automotive (ORLY) with a Neutral. 4. Blackhawk (HAWK) initiated with a Buy at Craig-Hallum. 5. Evercore Partners (EVR) initiated with a Neutral at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/17/17
GUGG
01/17/17
INITIATION
Target $880
GUGG
Buy
AutoZone initiated with a Buy at Guggenheim
Guggenheim analyst Steven Forbes initiated AutoZone with a Buy and a $880 price target.
02/07/17
JPMS
02/07/17
NO CHANGE
JPMS
JPMorgan sees buying opportunities in Autoparts Retailing
The recent selloff of names in Autoparts Retailing from weather and Amazon.com (AMZN) competition has created an attractive buying opportunity for the group, JPMorgan analyst Christopher Horvers tells investors in a research note. The analyst views AutoZone (AZO) as the most attractive from a valuation standpoint. He has Overweight ratings on the shares as well as Advance Auto Parts (AAP). Horvers is surprised Neutral-rated O'Reilly Automotive (ORLY) has sold off this much given its "best-in-class execution and lower weather risk." The risk from Amazon is "at worst glacial and likely a lot more manageable than the stocks are saying," the analyst writes. He feels bad news is already priced into the group.
WBA Walgreens Boots Alliance
$85.65

1.4 (1.66%)

02/06/17
ATLE
02/06/17
UPGRADE
ATLE
Overweight
Walgreens Boots upgraded to Overweight from Neutral at Atlantic Equities
01/20/17
01/20/17
NO CHANGE

Rite Aid-Walgreens deal closing 'way more likely than not,' says Cowen
After a Bloomberg article said that the FTC is concerned about the sale of Rite Aid (RAD) stores to Fred's (FRED) as a remedy to concerns about Walgreens' (WBA) takeover deal, Cowen analyst Charles Rhyee said that the report could reflect a split staff at FTC and the losing side making some noise or it could be a public negotiating tactic. Given the various paths forward, including litigation, Rhyee still thinks it is "way more likely than not" that this deal will ultimately close and views the weakness in Walgreens shares as a buying opportunity.
01/20/17
EVER
01/20/17
NO CHANGE
EVER
Rite Aid could trade to $3.50 or below if deal is not completed, says Evercore ISI
Evercore ISI analyst Ross Muken believes Rite Aid (RAD) could have "massive" downside and would likely trade to $3.50 or below if the acquisition by Walgreens Boots Alliance (WBA) were not completed. For Walgreens, Muken said, if the deal is not completed, it would be a modest negative given the synergy potential and time committed to deal closure, but he expects Walgreen not to sit on the capital for very long and would look for a combination of share repurchases and additional M&A in the not-too-distant future.
01/30/17
LEER
01/30/17
NO CHANGE
LEER
Outperform
Walgreens Boots Alliance, Rite Aid transaction still in-process, says Leerink
Leerink analyst David Larsen notes that he has confirmed with Walgreens Boots Alliance (WBA) that the deal with Rite Aid (RAD) would only terminate if either party were to walk away, which would require a formal announcement. Therefore, the analyst believes "no news is good news," and that the transaction is still in-process and on track. He reiterates an Outperform rating on Walgreens Boots Alliance's shares.
JCP J.C. Penney
$6.99

-0.04 (-0.57%)

02/17/17
02/17/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Buy at Citi by analyst Peter Christiansen, who said the company has the capability of "redefining" brick-and-mortar payments and commerce enablement. 2. Aerie Pharmaceuticals (AERI) initiated by Roth Capital analyst Sa'ar Yaniv with a Buy rating and $69 price target as he expects Rhopressa and Roclatan approval in 2018 and 2019. 3. Aegis analyst Chris Kapsch initiated Albemarle (ALB) with a Buy and a $108 price target, calling it a "must-own" stock over at least the next couple years. 4. Arch Coal (ARCH) initiated with a Buy at Jefferies by analyst Christopher LaFemina, citing the company's portfolio of "low-cost" U.S. coal assets and a "clean" balance sheet. 5. Piper Jaffray analyst Erinn Murphy assumed coverage of Nordstrom (JWN) with a Neutral rating and $41 price target, saying she believes price transparency may continue to hinder the company's results. Murphy also assumed coverage of J.C. Penney (JCP) with a Neutral rating and $8 price target, noting worries about the underlying secular pressure Amazon.com (AMZN) is putting on the industry, and assumed coverage of Kohl's (KSS) with a Neutral rating and $40 price target, as she believes earnings growth will be tough amid the current environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/17/17
PIPR
02/17/17
INITIATION
Target $8
PIPR
Neutral
J.C. Penney assumed with a Neutral at Piper Jaffray
Piper Jaffray analyst Erinn Murphy assumed coverage of J.C. Penney (JCP) with a Neutral rating and $8 price target. The analyst worries about the underlying secular pressure Amazon.com (AMZN) is putting on the industry.
02/13/17
02/13/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. J.C. Penney (JCP) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Kimberly Greenberger saying valuation appears more balanced following a 14% decline year-to-date and potential catalysts ahead. 2. Regeneron (REGN) upgraded to Overweight from Neutral at Piper Jaffray with analyst Edward Tenthoff saying that while Eylea growth is slowing, new approvals are coming. The analyst expects Dupixent approval in atopic dermatitis by the March 29 FDA action date and Phase III Liberty Asthma Quest data and potential supplemental Biologics License Application by year-end. 3. Petrobras (PBR) upgraded to Overweight from Neutral at JPMorgan with analyst Rodolfo Angele saying the shares are back to September 2016 levels despite "many positive" developments since then. 4. Nucor (NUE) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Evan Kurtz saying Nucor has more favorable risk/reward than AK Steel (AKS), which was downgraded to Equal Weight, given its low cost profile, margin stability, attractive end market mix, and potential benefits from favorable rulings on ongoing rebar and plate trade cases. 5. Allscripts (MDRX) upgraded to Buy from Neutral at Dougherty with analyst Gene Mannheimer citing a strong 2017 outlook partly due to Sunrise expansion, checks that indicate traction in the Allscripts open platform, and opportunities for growth from the NetSmart joint venture. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/13/17
02/13/17
UPGRADE

Equal Weight
J.C. Penney upgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley upgraded J.C. Penney to Equal Weight from Underweight. Analyst Kimberly Greenberger said valuation appears more balanced following a 14% decline year-to-date and potential catalysts ahead. The analyst has a new $7 price target, versus $8 previously, and a $12 bull case and $2 bear case values.
TSCO Tractor Supply
$70.85

-1.88 (-2.58%)

01/13/17
WEDB
01/13/17
UPGRADE
WEDB
Outperform
Tractor Supply upgraded to Outperform from Neutral at Wedbush
01/27/17
OPCO
01/27/17
NO CHANGE
Target $88
OPCO
Outperform
Tractor Supply price target raised to $88 from $80 at Oppenheimer
Oppenheimer analyst Brian Nagel raised his price target for Tractor Supply to $88 from $80 ahead of results. The analyst is optimistic that more normal weather and a stabilization in prices for oil and farm-related commodities likely helped to spur a modest improvement in Q4 sales. Further, Nagel says that his ongoing client conversations imply that investors are poised to re-embrace Tractor Supply's longer term story upon confirmation that recent sales disruptions were indeed transitory. He reiterates an Outperform rating on the shares.
02/03/17
RHCO
02/03/17
DOWNGRADE
RHCO
Hold
Tractor Supply downgraded to Hold from Buy at SunTrust
02/03/17
RHCO
02/03/17
DOWNGRADE
RHCO
Hold
Tractor Supply downgraded on negative catalysts at SunTrust
As noted earlier, SunTrust downgraded Tractor Supply to Hold from Buy. Analyst David Magee says that the company's growth is moderating, while it showed a number of other "weaknesses," including unpredictable weather.

TODAY'S FREE FLY STORIES

NKE

Nike

$61.50

0.195 (0.32%)

09:51
12/11/17
12/11
09:51
12/11/17
09:51
Upgrade
Nike rating change  »

Follow-up: Nike upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

IBB

iShares Nasdaq Biotechnology Index

$106.07

2.02 (1.94%)

09:50
12/11/17
12/11
09:50
12/11/17
09:50
Technical Analysis
Technical View: iShares Nasdaq Biotechnology Index breaks out »

The iShares Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$5.46

0.13 (2.44%)

09:50
12/11/17
12/11
09:50
12/11/17
09:50
Options
Interest in AK Steel Mar 7 calls continues »

Interest in AK Steel Mar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCE

Spark Therapeutics

$73.38

2.82 (4.00%)

09:48
12/11/17
12/11
09:48
12/11/17
09:48
Conference/Events
Spark Therapeutics to hold a pharmaceutical update conference call »

Management reviews the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 12

    Jan

NKE

Nike

$61.67

0.365 (0.60%)

09:47
12/11/17
12/11
09:47
12/11/17
09:47
Upgrade
Nike rating change  »

Nike upgraded to Positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

09:45
12/11/17
12/11
09:45
12/11/17
09:45
General news
JOLTS Job Openings to be reported at 10:00 »

October JOLTS Job…

IOTS

Adesto Technologies

$7.00

-0.45 (-6.04%)

09:44
12/11/17
12/11
09:44
12/11/17
09:44
Conference/Events
Adesto Technologies management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 14

    Dec

AGIO

Agios Pharmaceuticals

$60.97

0.14 (0.23%)

09:42
12/11/17
12/11
09:42
12/11/17
09:42
Conference/Events
Agios Pharmaceuticals to hold an investor meeting »

Investor Meeting where…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

KMB

Kimberly-Clark

09:41
12/11/17
12/11
09:41
12/11/17
09:41
Technical Analysis
Technical View: Kimberly-Clark falls in early trading, analyst action »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

, CELG

Celgene

$106.09

3.36 (3.27%)

09:40
12/11/17
12/11
09:40
12/11/17
09:40
Options
Unusually active option classes on open December 11th »

Unusual total active…

AKS

AK Steel

CELG

Celgene

$106.09

3.36 (3.27%)

GME

GameStop

CTL

CenturyLink

X

U.S. Steel

ORCL

Oracle

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Jan

  • 25

    Mar

09:40
12/11/17
12/11
09:40
12/11/17
09:40
General news
Fed funds futures are flat to lower ahead of Wednesday's FOMC »

Fed funds futures are…

ECR

Eclipse Resources

09:35
12/11/17
12/11
09:35
12/11/17
09:35
Conference/Events
Eclipse Resources to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTE

Baytex Energy

09:35
12/11/17
12/11
09:35
12/11/17
09:35
Downgrade
Baytex Energy rating change  »

Baytex Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNN

Smith & Nephew

09:33
12/11/17
12/11
09:33
12/11/17
09:33
Downgrade
Smith & Nephew rating change  »

Smith & Nephew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YPF

YPF

09:32
12/11/17
12/11
09:32
12/11/17
09:32
Upgrade
YPF rating change  »

YPF upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMS

Fresenius Medical

09:32
12/11/17
12/11
09:32
12/11/17
09:32
Downgrade
Fresenius Medical rating change  »

Fresenius Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEF

Telefonica

09:31
12/11/17
12/11
09:31
12/11/17
09:31
Downgrade
Telefonica rating change  »

Telefonica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEX

IDEX Corp.

09:31
12/11/17
12/11
09:31
12/11/17
09:31
Hot Stocks
IDEX Corp. announces acquisition of thinXXS Microtechnology AG »

IDEX Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

09:31
12/11/17
12/11
09:31
12/11/17
09:31
Downgrade
Home Depot rating change  »

Home Depot downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AIBSF

Allied Irish Banks

09:29
12/11/17
12/11
09:29
12/11/17
09:29
Downgrade
Allied Irish Banks rating change  »

Allied Irish Banks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$30.45

0.05 (0.16%)

09:29
12/11/17
12/11
09:29
12/11/17
09:29
Conference/Events
Argenx to hold a workshop »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

VTGN

VistaGen Therapeutics

$1.80

-0.23 (-11.33%)

09:27
12/11/17
12/11
09:27
12/11/17
09:27
Syndicate
VistaGen Therapeutics announces pricing of common stock and warrant offering »

VistaGen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

, CBOE

CBOE Holdings

$125.27

1.08 (0.87%)

09:26
12/11/17
12/11
09:26
12/11/17
09:26
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Fitbit (FIT), up…

FIT

Fitbit

CBOE

CBOE Holdings

$125.27

1.08 (0.87%)

NXPI

NXP Semiconductors

$115.29

0.16 (0.14%)

QURE

uniQure

$17.82

0.8 (4.70%)

CSIQ

Canadian Solar

$17.25

0.13 (0.76%)

PZRX

PhaseRx

$1.00

0.0126 (1.28%)

WPC

W.P. Carey

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NDAQ

Nasdaq

$78.78

0.99 (1.27%)

09:26
12/11/17
12/11
09:26
12/11/17
09:26
Recommendations
Nasdaq analyst commentary  »

Nasdaq price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RPT

Ramco-Gershenson

09:25
12/11/17
12/11
09:25
12/11/17
09:25
Conference/Events
Ramco-Gershenson to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.